Court Revives Doctors’ Suit Over FDA Anti-ivermectin Campaign

Published on September 1, 2023

Like a medical drama unfolding in the courtroom, a federal appeals court has breathed new life into a lawsuit brought by three doctors. They argue that the Food and Drug Administration (FDA) went too far in their efforts to dissuade the use of the anti-parasite drug ivermectin for treating COVID-19. It’s as if the doctors are playing the role of detectives, scrutinizing the actions of the FDA and seeking justice. This legal battle highlights an ongoing debate about the use of ivermectin as a potential treatment for COVID-19. While the FDA warns against its use, some doctors and patients believe it holds promise. With the case being revived, it remains to be seen how the court will ultimately rule and what impact it may have on future FDA campaigns. To learn more about this intriguing lawsuit and the complex issue of off-label drug use, dive into the research!

A federal appeals court Friday revived a lawsuit by three doctors who say the Food and Drug Administration overstepped its authority in a campaign against treating COVID-19 with the anti-parasite drug ivermectin.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>